title: Lactobacillus reuteri and Escherichia coli in the human gut microbiota may predict weight gain associated with vancomycin treatment.
abstract: BACKGROUND
  Antibiotics, used for 60 years to promote weight gain in animals, have been linked to obesity in adults and in children when administered during early infancy. Lactobacillus reuteri has been linked to obesity and weight gain in children affected with Kwashiorkor using ready-to-use therapeutic food. In contrast, Escherichia coli has been linked with the absence of obesity. Both of these bacteria are resistant to vancomycin.
  
  
  OBJECTIVE
  We assessed vancomycin-associated weight and gut microbiota changes, and tested whether bacterial species previously linked with body mass index (BMI) predict weight gain at 1 year. All endocarditis patients treated with vancomycin or amoxicillin in our center were included from January 2008 to December 2010. Bacteroidetes, Firmicutes, Lactobacillus and Methanobrevibacter smithii were quantified using real-time PCR on samples obtained during the 4-6 weeks antibiotic regimen. L. reuteri, L. plantarum, L. rhamnosus, Bifidobacterium animalis and E. coli were quantified on stool samples obtained during the first week of antibiotics.
  
  
  RESULTS
  Of the193 patients included in the study, 102 were treated with vancomycin and 91 with amoxicillin. Vancomycin was associated with a 10% BMI increase (odds ratio (OR) 14.1; 95% confidence interval (CI; 1.03-194); P=0.047) and acquired obesity (4/41 versus 0/56, P=0.01). In patients treated with vancomycin, Firmicutes, Bacteroidetes and Lactobacillus increased, whereas M. smithii decreased (P<0.05). The absence of E. coli was an independent predictor of weight gain (OR=10.7; 95% CI (1.4-82.0); P=0.02). Strikingly, a patient with an 18% BMI increase showed a dramatic increase of L. reuteri but no increase of E. coli.
  
  
  CONCLUSIONS
  The acquired obesity observed in patients treated with vancomycin may be related to a modulation of the gut microbiota rather than a direct antibiotic effect. L. reuteri, which is resistant to vancomycin and produces broad bacteriocins, may have an instrumental role in this effect.
authors.affiliation: Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes, Faculté de Médecine, CNRS UMR 7278, IRD 198, Aix-Marseille Université, Marseille, France.
authors.forename: M
authors.initials: M
authors.lastname: Million
authors.forename: F
authors.initials: F
authors.lastname: Thuny
authors.forename: E
authors.initials: E
authors.lastname: Angelakis
authors.forename: J-P
authors.initials: JP
authors.lastname: Casalta
authors.forename: R
authors.initials: R
authors.lastname: Giorgi
authors.forename: G
authors.initials: G
authors.lastname: Habib
authors.forename: D
authors.initials: D
authors.lastname: Raoult
references.citation: Br J Nutr. 2011 Apr;105(8):1235-44
references.pmid: 21303568
references.citation: J Infect Dis. 1996 May;173(5):1129-36
references.pmid: 8627064
references.citation: Appl Environ Microbiol. 1999 Nov;65(11):4949-56
references.pmid: 10543808
references.citation: Scand J Infect Dis. 2000;32(6):627-32
references.pmid: 11200372
references.citation: Neonatology. 2011;100(3):290-4
references.pmid: 21701222
references.citation: J Exp Med. 1963 Jan 31;117(2):245-57
references.pmid: 19867224
references.citation: Physiol Genomics. 2005 Oct 17;23(2):235-45
references.pmid: 16131529
references.citation: Appl Environ Microbiol. 1987 Feb;53(2):331-6
references.pmid: 3566269
references.citation: N Engl J Med. 2013 Jan 31;368(5):425-35
references.pmid: 23363496
references.citation: Nature. 2013 Jun 6;498(7452):99-103
references.pmid: 23719380
references.citation: Ann Trop Paediatr. 2008 Mar;28(1):13-22
references.pmid: 18318945
references.citation: Microb Pathog. 2013 Feb;55:52-4
references.pmid: 23332210
references.citation: Science. 2013 Feb 1;339(6119):548-54
references.pmid: 23363771
references.citation: Eur J Clin Microbiol Infect Dis. 1993 Sep;12(9):714-9
references.pmid: 8243490
references.citation: Int J Obes (Lond). 2011 Apr;35(4):522-9
references.pmid: 21386800
references.citation: Scand J Infect Dis. 1994;26(2):191-7
references.pmid: 8036475
references.citation: Clin Infect Dis. 1997 Sep;25(3):729-32
references.pmid: 9314469
references.citation: Curr Infect Dis Rep. 2013 Feb;15(1):25-30
references.pmid: 23129415
references.citation: Antimicrob Agents Chemother. 2012 Nov;56(11):5811-20
references.pmid: 22948872
references.citation: J Nutr. 1955 May 10;56(1):151-61
references.pmid: 14368380
references.citation: Proc Natl Acad Sci U S A. 2010 Apr 20;107(16):7503-8
references.pmid: 20363958
references.citation: J Biol Chem. 1949 Sep;180(2):647-54
references.pmid: 18135798
references.citation: Clin Microbiol Infect. 2013 Apr;19(4):305-13
references.pmid: 23452229
references.citation: Thorax. 2006 Oct;61(10):895-902
references.pmid: 16809416
references.citation: J Antimicrob Chemother. 1996 Dec;38(6):927-39
references.pmid: 9023640
references.citation: Infection. 1991 Jul-Aug;19(4):208-15
references.pmid: 1917031
references.citation: Br J Nutr. 1959;13(1):78-84
references.pmid: 13628943
references.citation: J Antibiot (Tokyo). 1955 Dec;8(6):212-4
references.pmid: 13353927
references.citation: Nature. 2006 Dec 21;444(7122):1022-3
references.pmid: 17183309
references.citation: PLoS One. 2012;7(10):e46837
references.pmid: 23056479
references.citation: J Cyst Fibros. 2003 Jun;2(2):69-71
references.pmid: 15463852
references.citation: Obesity (Silver Spring). 2010 Jan;18(1):190-5
references.pmid: 19498350
references.citation: Arch Intern Med. 2009 Jul 27;169(14):1290-8
references.pmid: 19636030
references.citation: Clin Infect Dis. 2000 Apr;30(4):633-8
references.pmid: 10770721
references.citation: Science. 2013 Mar 1;339(6123):1084-8
references.pmid: 23328391
references.citation: Aliment Pharmacol Ther. 2011 Apr;33(8):922-9
references.pmid: 21366634
references.citation: Pediatr Pulmonol. 2012 Jul;47(7):641-8
references.pmid: 22684984
references.citation: Microb Pathog. 2012 Aug;53(2):100-8
references.pmid: 22634320
references.citation: J Proteome Res. 2008 Sep;7(9):3718-28
references.pmid: 18698804
references.citation: PLoS One. 2009 Sep 17;4(9):e7063
references.pmid: 19759898
references.citation: Clin Pediatr (Phila). 1977 Jan;16(1):60-3
references.pmid: 830461
references.citation: Int J Obes (Lond). 2012 Jun;36(6):817-25
references.pmid: 21829158
references.citation: PLoS One. 2009 Sep 23;4(9):e7125
references.pmid: 19774074
references.citation: Nature. 2012 Aug 30;488(7413):621-6
references.pmid: 22914093
references.citation: Dig Liver Dis. 2005 Jan;37(1):39-43
references.pmid: 15702858
references.citation: Antimicrob Agents Chemother. 2013 Aug;57(8):3659-66
references.pmid: 23689712
references.citation: Int J Obes (Lond). 2013 Jan;37(1):16-23
references.pmid: 22907693
references.citation: Int J Obes (Lond). 2013 Nov;37(11):1460-6
references.pmid: 23459324
references.citation: Appl Microbiol. 1967 Sep;15(5):1229-34
references.pmid: 6077418
references.citation: Gut Microbes. 2010 Jul;1(4):279-284
references.pmid: 20953272
references.citation: PLoS One. 2010 Feb 10;5(2):e9074
references.pmid: 20161775